Primary chemotherapy followed by anterior craniofacial resection and radiotherapy for paranasal cancer

Annals of Oncology

Volumn 14, Issue 3, 2003, Pages 367-372

  Licitra, Lisa ^a   Locati, L D ^a   Cavina, R ^a   Garassino, I ^a   Mattevelli, F ^a   Pizzi, N ^a   Quattrone, P ^a   Valagussa, P ^a   Gianni, L ^a   Bonadonna, G ^a   Solero, C L ^b   Cantu, G ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b Second Division of Neurosurgery   (Italy)

Author keywords

Anterior craniofacial resection; Paranasal cancer; Primary chemotherapy

Indexed keywords

ANTIEMETIC AGENT; CISPLATIN; FLUOROURACIL; FOLINIC ACID;

ADULT; AGED; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER REGRESSION; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CRANIOFACIAL SURGERY; DIARRHEA; DRUG RESPONSE; DRUG WITHDRAWAL; FEMALE; HEART ARRHYTHMIA; HEART DISEASE; HEART MUSCLE ISCHEMIA; HEMATOLOGIC DISEASE; HUMAN; HYPERTENSION; MALE; MULTIMODALITY CANCER THERAPY; NAUSEA AND VOMITING; PARANASAL SINUS CANCER; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; STOMATITIS; THROMBOSIS;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA; CISPLATIN; FEMALE; FLUOROURACIL; HUMANS; INFUSIONS, INTRAVENOUS; LEUCOVORIN; MALE; MIDDLE AGED; PARANASAL SINUS NEOPLASMS; PROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 12244254471     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1093/annonc/mdg113     Document Type: Article

References (30)

1. Cheng V, Wang C. Carcinomas of the paranasal sinuses. Cancer 1977; 40: 3038-3041.
2. Bush SE, Bagshaw MA. Carcinoma of the paranasal sinuses. Cancer 1982; 50: 154-158.
3. Spiro JD, Soo KC, Spiro RH. Squamous carcinoma of the nasal cavity and paranasal sinuses. Am J Surg 1989; 158: 328-332.
4. Lavertu P, Roberts JK, Kraus DH et al. Squamous cell carcinoma of the paranasal sinuses: the Cleveland Clinic experience 1977-1986. Laryngoscope 1989; 99: 1130-1136.
5. Waldron JN, O'Sullivan B, Warde P et al. Ethmoid sinus cancer: twenty-nine cases managed with primary radiation. Int J Radiat Oncol Biol Phys 1998; 41: 361-369.
6. Jiang GL, Morrison WH, Garden AS et al. Ethmoid sinus carcinomas: natural history and treatment results. Radiother Oncol 1998; 49: 21-27.
7. Dilhuydy JM, Lagarde P, Allal AS et al. Ethmoidal cancers: a retrospective study of 22 cases. Int J Radiat Oncol Biol Phys 1993; 25: 113-116.
8. Ketcham AS, Van Buren JM. Tumors of the paranasal sinuses: a therapeutic challenge. Am J Surg 1985; 150: 406-413.
9. Cantù G, Solero CL, Mariani L et al. Anterior craniofacial resection for malignant ethmoid tumors: a series of 91 patients. Head Neck 1999; 21: 185-191.
10. LoRusso P, Tapazoglou E, Kish JA et al. Chemotherapy for paranasal sinus carcinoma. A 10-year experience at Wayne State University. Cancer 1988; 62: 1-5.
11. Rosen A, Vokes EE, Scher N et al. Locoregionally advanced paranasal sinus carcinoma. Favorable survival with multimodality therapy. Arch Otolaryngol Head Neck Surg 1993; 119: 743-746.
12. Brasnu D, Laccourreye O, Bassot V et al. Cisplatin-based neoadjuvant chemotherapy and combined resection for ethmoid sinus adenocarcinoma reaching and/or invading the skull base. Arch Otolaryngol Head Neck Surg 1996; 122: 765-768.
13. Björk-Eriksson T, Mercke C, Petruson B et al. Potential impact on tumor control and organ preservation with cisplatin and 5-fluorouracil for patients with advanced tumors of the paranasal sinuses and nasal fossa. A prospective pilot study. Cancer 1992; 70: 2615-2620.
14. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457-481.
15. Peto R, Peto J. Asymptomatically efficient rank invariant test procedures. J R Stat Soc A 1972; 135: 185-198.
16. Ensley J, Kish J, Tapazoglou E et al. An intensive, five course, alternating combination chemotherapy induction regimen used in patients with advanced, unresectable head and neck cancer. J Clin Oncol 1988; 6: 1147-1153.
17. Vokes EE, Schilsky RL, Weichselbaum RR et al. Induction chemotherapy with cisplatin, fluorouracil and high-dose leucovorin for locally advanced head and neck cancer: a clinical and pharmacologic analysis. J Clin Oncol 1990; 8: 241-247.
18. Clark JR, Busse PM, Norris CM Jr et al. Induction chemotherapy with cisplatin, fluorouracil and high-dose leucovorin for squamous cell carcinoma of the head and neck: long-term results. J Clin Oncol 1997; 15: 3100-3110.
19. Schneider M, Etienne MC, Milano G et al. Phase II trial of cisplatin, fluorouracil and pure folinic acid for locally advanced head and neck cancer: a pharmacokinetic and clinical survey. J Clin Oncol 1995; 13: 1656-1662.
20. Alba E, Sanchez-Chaparro MA, Alonso L et al. Cisplatin, 5-fluorouracil and high dose folinic in patients with advanced unresectable head and neck cancer. Am J Clin Oncol 1996; 19: 140-143.
21. Dreyfuss AI, Clark JR, Wright JE et al. Continuous infusion high-dose leucovorin with 5-fluorouracil and cisplatin for untreated stage IV carcinoma of the head and neck. Ann Intern Med 1990; 112: 167-172.
22. Papadimitrakopoulou VA, Dimery IW, Lee JJ et al. Cisplatin, fluorouracil, and L- leucovorin induction chemotherapy for locally advanced head and neck cancer: the M.D. Anderson Cancer Center experience. Cancer J Sci Am 1997; 3: 92-99.
23. Pfister DG, Bajorin D, Motzer R et al. Cisplatin, fluorouracil, and leucovorin. Increased toxicity without improved response in squamous cell head and neck cancer. Arch Otolatyngol Head Neck Surg 1994; 120: 89-95.
24. Cognetti F, Pinnaro P, Ruggeri EM et al. Prognostic factors for chemotherapy response and survival using combination chemotherapy as initial treatment of advanced head and neck squamous cell cancer. J Clin Oncol 1989; 7: 829-837.
25. Al-Kourainy K, Kish J, Ensley J et al. Achievement of superior survival for histologically negative versus histologically positive clinically complete responders to cisplatin combination in patients with locally advanced head and neck cancer. Cancer 1987; 59: 233-238.
26. Rooney M, Kish J, Jacobs J et al. Improved complete response rate and survival in advanced head and neck cancer after three-course induction therapy with 120-hour 5-FU infusion and cisplatin. Cancer 1985; 55: 1123-1128.
27. Lund VJ, Howard DJ, Lloyd GA et al. Magnetic resonance imaging of paranasal sinus tumors for craniofacial resection. Head Neck 1989; 11: 279-283.
28. Lowe JV, Dunphy FR, Varvares M et al. Evaluation of chemotherapy response I patients with advanced head and neck cancer using [F-18] fluorodeoxyglucose positron emission tomography. Head Neck 1997; 19: 666-674.
29. Vokes EE, Weichselbaum RR, Mick R et al. Favorable long-term survival following induction chemotherapy with cisplatin, fluorouracil and leucovorin and concomitant chemoradiotherapy for locally advanced head and neck cancer. J Natl Cancer Inst 1992; 84: 877-882.
30. Rezkalla S, Kloner RA, Ensley J et al. Continuous ambulatory ECG monitoring during fluorouracil therapy: a prospective study. J Clin Oncol 1989; 7: 509-514.